Table 1.
Demographic and disease characteristics of the groups
| Variable | HIV− (n=48) | HIV+ (n=60) | P value |
|---|---|---|---|
| Age1 | 42.9 (11.3) | 42.5 (9.1) | 0.82 |
| Education1 | 9.1 (4.4) | 9.1 (4.3) | 0.996 |
| Male n (%) | 25 (52%) | 30 (50%) | 0.98 |
| HCV+ n (%)3 | 0 (0%) | 12 (20%) | |
| Duration of HIV (months) | – | 99 [29–140] | – |
| CD4 Nadir2 | – | 88 [28–268] | – |
| CD4 Current2 | – | 372 [193–547] | |
| plasma HIV viral load2 | – | 1.7 [1.7–3.1] | |
| Plasma HIV RNA ≤50 copies/ml n (%) | – | 35 (58%) | – |
| CSF HIV viral load2 | – | 1.7 [1.7–2.8] | |
| CSF HIV RNA ≤50 copies/ml n (%) | – | 32 (53%) | – |
| on ARV n (%) | – | 47 (78%) | – |
| AIDS diagnosis n (%) | – | 48 (80%) | – |
1
mean (SD);
2
median [IQR];
3
HIV− were selected to be HCV–